The Harvard Drug Group LLC (dba Major Pharmaceuticals and Rugby Laboratories) has recalled 6,086 blister packs of Major brand ChlorproMAZINE Hydrochloride Tablets, a prescription antipsychotic medication, due to the presence of N-Nitroso Desmethyl Chlorpromazine at levels above the recommended intake limit. The recall affects 25 mg, 50 mg, 100 mg, and 200 mg strengths packaged in 50-count and 100-count blister packs. Consumers should check their medicine for the affected lot numbers and expiration dates, which range from September 2025 to June 2026.
The tablets contain a nitrosamine impurity (N-Nitroso Desmethyl Chlorpromazine) that exceeds safe daily intake levels; long-term exposure to elevated levels of nitrosamines is associated with an increased risk of cancer.
You have 2 options:
5x10 blister package
10x10 blister package
10x10 blister package
10x10 blister package
10x10 blister package
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.